Access to safe effective affordable medicines is one of the most important public health considerations in Ghana and in the African Region as a whole. However the majority of people in the region do not have regular access to good quality safe and affordable essential medicines. Available data suggest that there is increasing prevalence of resistance to antibiotics and a marked decrease in development of new antimicrobials with novel mechanism of action.
The annual reports of the pharmacy division of the MoH over the years depict high level of use of antibiotics at the Out Patient Department (OPD) at the hospitals. The pharmaceutical sector strategic plan (2012 – 2014) seeks to address this phenomenon by developing a comprehensive National Anti-biotic Use and Resistance Surveillance policy that will ameliorate the situation. [Download full concept note for Ghana]
The discovery of more antibiotics in the 1940s significantly contributed to infectious disease therapy thereby reducing morbidity and mortality from bacterial infections. Despite the contribution of antibiotics to health and wellness, many bacteria strains have and continue to develop resistance to antibiotics at an alarming rate. Resistance to antibiotics, though a natural phenomenon has seen an increase in prevalence which has been attributed mainly to inappropriate use of antibiotics, or inefficient management of infectious diseases both in health facilities and in the community.
ReAct Country Coordinator:
Mrs Martha Gyansa-Lutterodt
ReAct CSO project Coordinator:
Name: Mr George Hedidor